Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Alberta

$32,000.00

Studies on a novel T cell regulatory molecule

FY 2019-20

Summary
T lymphocytes (T cells) are central to adaptive immune responses and maintaining homeostasis. However, aberrant T cell immune responses can cause severe damage to an organism. The balance in homeostasis vs. damage is finely tuned by a multitude of regulatory mechanisms. Many non-redundant inhibitory pathways are turned on in parallel with the activation of T cells. Interestingly, through evolution, multiple parallel inhibitory pathways have emerged which work in concert to maintain self-tolerance and limit the scope of collateral damage upon induction of immunological responses in the peripheral system. Investigating how these pathways work enables a better understanding of the function and regulation of adaptive immunity and biology of the immune system.******MUC1 mucin (CD227), has long been known to be expressed by epithelial cells. For the first time, I discovered that MUC1 is also expressed by activated human T cells which provided the first evidence of the role of MUC1 as a novel T cell regulator. These original and highly cited (125 times) findings were followed by researchers worldwide, and established MUC1 as a novel T cell immunoregulatory molecule. In our subsequent studies, we have shown that MUC1 is expressed differentially on nave, memory and effector CD4+ and CD8+ T cells, and is highly expressed on regulatory T cells with a putative function as an important T cell immune regulator. Based on these preliminary studies, I hypothesize that MUC1 is an important checkpoint/regulatory molecule of T cells, and that investigating the role of MUC1 in T cell biology is fundamental to our understanding of T cell responses and immune homeostasis. The goal of this proposal is to study this yet unexplored T cell regulatory molecule and unravel its exact role in regulating immune responses. The specific aims are to:******Aim 1: Investigate the function of MUC1 in regulating various subsets of human T cells (CD4, CD8, nave, effector, effector memory, central memory, and regulatory T cells) and its relative role/function with other regulatory molecules.******Aim 2: Determine the interaction of MUC1 expressed on T cells with its putative ligand(s).******The PI has extensive expertise with a proven track-record in immunobiology research, has a fully equipped lab and access to flow cytometry and confocal microscopy facilities and is proficient with all the techniques and methodologies to be used in this proposal.******The proposed studies will advance our knowledge in natural sciences and immunobiology, provide critical new information of a novel T cell immunoregulatory molecule and dissect specific pathways for a novel checkpoint molecule. Understanding the role of MUC1, alone and co-expressed with other checkpoints, will lead to a better understanding of the “fine-tuning” of T cell responses in an organism.*****
Program
Discovery Grants Program - Individual
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2019-04407
Name nom
Agrawal, Babita
Department département
Surgery
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
32000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5102
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Inter-cellular communication
Research subject fr
Communication inter-cellulaire
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Studies on a novel T cell regulatory molecule
Keyword
NSERC
Application summary
T lymphocytes (T cells) are central to adaptive immune responses and maintaining homeostasis. However, aberrant T cell immune responses can cause severe damage to an organism. The balance in homeostasis vs. damage is finely tuned by a multitude of regulatory mechanisms. Many non-redundant inhibitory pathways are turned on in parallel with the activation of T cells. Interestingly, through evolution, multiple parallel inhibitory pathways have emerged which work in concert to maintain self-tolerance and limit the scope of collateral damage upon induction of immunological responses in the peripheral system. Investigating how these pathways work enables a better understanding of the function and regulation of adaptive immunity and biology of the immune system.******MUC1 mucin (CD227), has long been known to be expressed by epithelial cells. For the first time, I discovered that MUC1 is also expressed by activated human T cells which provided the first evidence of the role of MUC1 as a novel T cell regulator. These original and highly cited (125 times) findings were followed by researchers worldwide, and established MUC1 as a novel T cell immunoregulatory molecule. In our subsequent studies, we have shown that MUC1 is expressed differentially on nave, memory and effector CD4+ and CD8+ T cells, and is highly expressed on regulatory T cells with a putative function as an important T cell immune regulator. Based on these preliminary studies, I hypothesize that MUC1 is an important checkpoint/regulatory molecule of T cells, and that investigating the role of MUC1 in T cell biology is fundamental to our understanding of T cell responses and immune homeostasis. The goal of this proposal is to study this yet unexplored T cell regulatory molecule and unravel its exact role in regulating immune responses. The specific aims are to:******Aim 1: Investigate the function of MUC1 in regulating various subsets of human T cells (CD4, CD8, nave, effector, effector memory, central memory, and regulatory T cells) and its relative role/function with other regulatory molecules.******Aim 2: Determine the interaction of MUC1 expressed on T cells with its putative ligand(s).******The PI has extensive expertise with a proven track-record in immunobiology research, has a fully equipped lab and access to flow cytometry and confocal microscopy facilities and is proficient with all the techniques and methodologies to be used in this proposal.******The proposed studies will advance our knowledge in natural sciences and immunobiology, provide critical new information of a novel T cell immunoregulatory molecule and dissect specific pathways for a novel checkpoint molecule. Understanding the role of MUC1, alone and co-expressed with other checkpoints, will lead to a better understanding of the “fine-tuning” of T cell responses in an organism.*****